Juvenescence and M42 will establish a leading drug development hub in Abu Dhabi, led by an unrivalled team, to build a therapeutics pipeline to extend healthy lifespan. Leveraging M42’s deep ...

Abu Dhabi’s state-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based firm focused on developing drugs to expand human lifespans. M42 ...

Juvenescence Ltd., a clinical-stage biotech leveraging AI to target age-related diseases, has announced the successful first ...

Shutterstock Abu Dhabi: Abu Dhabi-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based firm focused on developing drugs to expand human lifespans.

M42 was launched by G42 Healthcare , the healthcare arm of the UAE's global AI and cloud computing company, G42 , and Mubadala Health, the healthcare arm of the Abu Dhabi-based sovereign wealth ...

Abu Dhabi Health Data Services (ADHDS), at the core of M42’s Digital Health Solutions Platform (DHS), is a premier digital healthcare solutions company serving as a strategic catalyst for ...

a major government initiative by the Department of Health – Abu Dhabi (DoH) that seeks to advance the future of health and well-being. With this new facility, M42 and Cleveland Clinic Abu Dhabi are ...

M42, a global health champion powered by AI and technology, said its group company Cleveland Clinic Abu Dhabi is set to build the region’s first heavy-ion therapy facility in Abu Dhabi, a move seen as ...

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...

Juvenescence and M42 will establish a leading drug development hub in Abu Dhabi, led by an unrivalled team, to build a therapeutics pipeline to extend healthy lifespan. Leveraging M42's deep expertise ...